These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. [Modification of serum lipoproteins by soy bean proteins]. Richter WO; Weisweiler P; Schwandt P MMW Munch Med Wochenschr; 1981 Nov; 123(46):1755-6. PubMed ID: 6796844 [No Abstract] [Full Text] [Related]
30. [Fibrin stabilization and factor XIII substitution in malignant tumors (author's transl)]. Zöller H Arzneimittelforschung; 1977 Jul; 27(7):1500-2. PubMed ID: 578483 [No Abstract] [Full Text] [Related]
31. [Theoretical and clinical aspects of fibrin stabilization in the post-operative phase]. Schwering H; Zimmermann RE; Wittrin G; Kessler B Chirurg; 1981 Jan; 52(1):41-5. PubMed ID: 7471966 [TBL] [Abstract][Full Text] [Related]
32. Acquired factor XIII inhibitor in monoclonal gammopathy of undetermined significance: characterization and cross-linked fibrin ultrastructure. Luo Y; Zhang G; Zuo W; Zheng W; Dai C Ann Hematol; 2010 Aug; 89(8):833-4. PubMed ID: 19953252 [No Abstract] [Full Text] [Related]
33. Alterations of haemostasis parameters with special reference to fibrin stabilization, factor XIII and fibronectin in patients with obliterative atherosclerosis. Kłoczko J; Wojtukiewicz M; Bielawiec M; Zuch A Thromb Res; 1988 Sep; 51(6):575-81. PubMed ID: 3187967 [TBL] [Abstract][Full Text] [Related]
34. [Effect of bezafibrate on disorders of lipid metabolism]. Stryjek-Kamińska D; Ilińska-Debniak K; Bartosiewicz W; Szczepanik Z Pol Tyg Lek; 1983 Dec; 38(50):1567-71. PubMed ID: 6379618 [No Abstract] [Full Text] [Related]
35. Biochemical abnormalities associated with ocular hypertension and low tension glaucoma. Winder AF; Paterson G; Miller SJ Trans Ophthalmol Soc U K (1962); 1974 Jul; 94(2):518-24. PubMed ID: 4377696 [No Abstract] [Full Text] [Related]
36. [Dyslipidemia and blood coagulation]. Serrano Júnior CV; Ramires JA Arq Bras Cardiol; 1995 Sep; 65(3):273-7. PubMed ID: 8579517 [No Abstract] [Full Text] [Related]
37. Evidence for abnormalities in clotting and thrombolysis as a risk factor for stroke. Pilgeram LO; Chee AN; Von dem Bussche G Stroke; 1973; 4(4):643-57. PubMed ID: 4723694 [No Abstract] [Full Text] [Related]
38. [Characteristics of lipoprotein metabolism impairments in nephrotic syndrome]. Titov VN; Tvorogova MG; Levitova EN; Krylova EA Vopr Med Khim; 1983; 29(2):17-23. PubMed ID: 6858031 [TBL] [Abstract][Full Text] [Related]
39. Detection and differentiation of primary hyperlipoproteinemias. Plamieniak Z Mater Med Pol; 1974; 6(3):227-34. PubMed ID: 4374608 [No Abstract] [Full Text] [Related]
40. Lysis of clots prepared from whole blood and plasma. Taylor FB; Carroll RC; Gerrard J; Esmon CT; Radcliffe RD Fed Proc; 1981 May; 40(7):2092-8. PubMed ID: 7194803 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]